[HTML][HTML] A review of the current ERAS guidelines for liver resection, liver transplantation and pancreatoduodenectomy

N Bayramov, S Mammadova - Annals of Medicine and Surgery, 2022 - Elsevier
In perioperative care after liver resection, transplantation and pancreatoduodenectomy,
ERAS (Enhanced Recovery After Surgery) recommendations are based on the reducing …

Somatostatin analogues and the risk of post-operative pancreatic fistulas after pancreatic resection-A systematic review & meta-analysis

T Li, RT D'Cruz, SY Lim, VG Shelat - Pancreatology, 2020 - Elsevier
Background Post-operative pancreatic fistula (POPF) is a common complication of
pancreatic resection. Somatostatin analogues (SA) have been used as prophylaxis to …

Effect of hydrocortisone vs pasireotide on pancreatic surgery complications in patients with high risk of pancreatic fistula: a randomized clinical trial

T Tarvainen, J Sirén, A Kokkola, V Sallinen - JAMA surgery, 2020 - jamanetwork.com
Importance Both hydrocortisone and pasireotide have been shown in randomized clinical
trials to be effective in reducing postoperative complications of pancreatic surgery, but to …

[HTML][HTML] Somatostatin analogues for the prevention of pancreatic fistula after open pancreatoduodenectomy: A nationwide analysis

BT Bootsma, VD Plat, T van de Brug, DE Huisman… - Pancreatology, 2022 - Elsevier
Background Somatostatin analogues (SA) are currently used to prevent postoperative
pancreatic fistula (POPF) development. However, its use is controversial. This study …

[HTML][HTML] Non-Surgical Interventions for the Prevention of Clinically Relevant Postoperative Pancreatic Fistula—A Narrative Review

N Rykina-Tameeva, JS Samra, S Sahni, A Mittal - Cancers, 2023 - mdpi.com
Simple Summary Clinically relevant postoperative pancreatic fistula (CR-POPF) continues to
be the leading cause of morbidity and mortality after pancreatic surgery. Attempts to prevent …

A randomised, multicentre trial of somatostatin to prevent clinically relevant postoperative pancreatic fistula in intermediate-risk patients after …

Z Cao, J Qiu, J Guo, G Xiong, K Jiang, S Zheng… - Journal of …, 2021 - Springer
Background Prophylactic somatostatin to reduce the incidence of clinically relevant
postoperative pancreatic fistula after pancreaticoduodenectomy remains controversial. We …

[HTML][HTML] Systematic review and meta-analysis of surgical drain management after the diagnosis of postoperative pancreatic fistula after pancreaticoduodenectomy …

S Pedrazzoli, AR Brazzale - Langenbeck's Archives of Surgery, 2020 - Springer
Purpose Drains' role after pancreaticoduodenectomy (PD) is debated by proponents of no
drain, draining selected cases, and early drain removal. The aim of the study was to assess …

[HTML][HTML] Prevention and treatment of grade C postoperative pancreatic fistula

C Xiang, Y Chen, X Liu, Z Zheng, H Zhang… - Journal of Clinical …, 2022 - mdpi.com
Postoperative pancreatic fistula (POPF) is a troublesome complication after pancreatic
surgeries, and grade C POPF is the most serious situation among pancreatic fistulas. At …

[HTML][HTML] Prophylactic octreotide for postoperative pancreatic fistula in patients with pancreatoduodenectomy: Risk-stratified analysis

SJ Yoon, O Lee, JH Jung, SH Shin, JS Heo, IW Han - Medicine, 2022 - journals.lww.com
Background: Postoperative pancreatic fistula is one of the most critical complications
following pancreatic surgery. This study aimed to evaluate the utility of selective prophylactic …

[HTML][HTML] Neck transection level and postoperative pancreatic fistula after pancreaticoduodenectomy: A retrospective cohort study of 195 patients

T Bardol, J Delicque, M Hermida, A Herrero… - International Journal of …, 2020 - Elsevier
Background The aim of this study was to evaluate the impact of the level of neck transection
on clinically relevant postoperative pancreatic fistula (CR-POPF) after standard …